Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor
(SiFA) 18F-Radiopharmaceuticals

​

Gower-Fry L, Kronemann T, Dorian A, Pu Y, Jaworski C, Wängler C, Bartenstein P, Beyer L, Lindner S, Jurkschat K, Wängler B, Bailey JJ, Schirrmacher R.

Pharmaceuticals (Basel). 2021 Jul 20;14(7):701. doi: 10.3390/ph14070701.

 

 

Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours.

Beyer L, Gosewisch A, Lindner S, Völter F, Mittlmeier LM, Tiling R, Brendel M, Cyran CC, Unterrainer M, Rübenthaler J, Auernhammer CJ, Spitzweg C, Böning G, Gildehaus FJ, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Wenter V, Todica A, Bartenstein P, Ilhan H.

Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3571-3581. doi: 10.1007/s00259-021-05351-x. Epub 2021 Apr 29.

 

PET Imaging of Meningioma Using the Novel SSTR-Targeting Peptide 18F-SiTATE.

Unterrainer M, Lindner S, Beyer L, Gildehaus FJ, Todica A, Mittlmeier LM, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Tonn JC, Albert NL, Bartenstein P, Ilhan H.

Clin Nucl Med. 2021 Aug 1;46(8):667-668. doi: 10.1097/RLU.0000000000003607.

 

Radiosynthesis of [18F]SiFAlin-TATE for clinical neuroendocrine tumor positron emission tomography.

Lindner S, Wängler C, Bailey JJ, Jurkschat K, Bartenstein P, Wängler B, Schirrmacher R.

Nat Protoc. 2020 Dec;15(12):3827-3843. doi: 10.1038/s41596-020-00407-y. Epub 2020 Nov 23.

 

Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors.

Ilhan H, Lindner S, Todica A, Cyran CC, Tiling R, Auernhammer CJ, Spitzweg C, Boeck S, Unterrainer M, Gildehaus FJ, Böning G, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Bartenstein P.

Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):870-880. doi: 10.1007/s00259-019-04501-6. Epub 2019 Sep 6.